Latest News
Saxo Markets: Gaming company Sumo is top stock of the week on London Stock Exchange after Tencent £900m buyout
In today’s Saxo Markets’ Weekly Winners for the London Stock Exchange and internationally:
– Sumo Group’s £900million buyout sees shares rise 39.24% on the London Stock Exchange
– GCP Student Living among Weekly Winners list for fourth week running
– Next, Trainline and Cineworld see growth in past week as England eases lockdown restrictions
LSE |
Weekly Winners |
% Price Rise in Past 7 Days |
Sumo Group |
39.24% |
|
Ultra Electronics Holdings |
39.15% |
|
Frontier Developments |
17.92% |
|
3i Group Plc |
11.15% |
|
GCP Student Living |
10.68% |
|
Cineworld Group |
10.61% |
|
Future Plc |
10.33% |
|
Biffa Plc |
10.28% |
|
Keywords Studios |
10.14% |
|
Blue Prism Group |
9.32% |
|
Next |
9.32% |
|
FDM Group |
8.60% |
|
Volution Group Plc |
7.90% |
|
Trainline Plc |
7.58% |
|
Morgan Sindall |
7.55% |
Correct as of 6.00am (BST) 26.07.2021
*Includes only companies with market caps greater than 1 Billion USD
Globally across all exchanges:
– Cytokinetics is this week’s top performer seeing shares rise 50.31% after success of clinical trials for new heart-disease drug
– Moderna Inc, the company behind one of Europe’s most used Covid vaccines, has share spike after having jab authorised for teenagers
– Snap Inc. among top 15 stocks as Q2 results boast positive revenue figures
All |
Weekly Winners |
% Price Rise in Past 7 Days |
Cytokinetics Inc. |
50.31% |
|
Cassava Science |
49.68% |
|
Veoneer Inc. |
49.07% |
|
Apollo Medical Holdings |
44.57% |
|
Sumo Group |
39.24% |
|
Ultra Electronics Holdings |
39.15% |
|
Anhui Jianghuai Automobile |
38.93% |
|
Moderna Inc. |
34.33% |
|
Arvinas Inc. |
30.42% |
|
Nurix Therapeutics |
30.17% |
|
Westshore Terminals |
29.30% |
|
Snap Inc. |
28.88% |
|
Quidel Corp. |
28.64% |
|
San’An Optoelectronics |
28.57% |
|
Shangai Wanye |
28.21% |
Correct as of 6.00am (BST) 26.07.2021
*Includes only companies with market caps greater than 1 Billion USD
All trading carries risk. Any past performance stated is not an indication of future performance.